These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9435799)

  • 1. [Tracking the gatekeeper gene in the stages of carcinogenesis in the bladder].
    Baud E; Catilina P; Bignon YJ
    Bull Cancer; 1997 Oct; 84(10):971-5. PubMed ID: 9435799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two molecular pathways to transitional cell carcinoma of the bladder.
    Spruck CH; Ohneseit PF; Gonzalez-Zulueta M; Esrig D; Miyao N; Tsai YC; Lerner SP; Schmütte C; Yang AS; Cote R
    Cancer Res; 1994 Feb; 54(3):784-8. PubMed ID: 8306342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
    Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
    Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia.
    Chaturvedi V; Li L; Hodges S; Johnston D; Ro JY; Logothetis C; von Eschenbach AC; Batsakis JG; Czerniak B
    Oncogene; 1997 May; 14(17):2059-70. PubMed ID: 9160886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene P53 (TP53) in patients with bladder cancer.
    Ecke TH; Lenk SV; Schlechte HH; Loening SA
    Anticancer Res; 2003; 23(2A):957-62. PubMed ID: 12820330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The random development of LOH on chromosome 9q in superficial bladder cancers.
    van Tilborg AA; de Vries A; de Bont M; Groenfeld LE; Zwarthoff EC
    J Pathol; 2002 Nov; 198(3):352-8. PubMed ID: 12375268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of tumor suppressor genes in bladder cancer.
    Cordon-Cardo C; Reuter VE
    Semin Diagn Pathol; 1997 May; 14(2):123-32. PubMed ID: 9179973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer.
    Dalbagni G; Presti JC; Reuter VE; Zhang ZF; Sarkis AS; Fair WR; Cordon-Cardo C
    Diagn Mol Pathol; 1993 Mar; 2(1):4-13. PubMed ID: 7904525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cigarette smoking and chromosome 9 alterations in bladder cancer.
    Zhang ZF; Shu XM; Cordon-Cardo C; Orlow I; Lu ML; Millon TV; Cao PQ; Connolly-Jenks C; Dalbagni G; Lianes P; Lacombe L; Reuter VE; Scher H
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):321-6. PubMed ID: 9149891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.
    Jarmalaite S; Jankevicius F; Kurgonaite K; Suziedelis K; Mutanen P; Husgafvel-Pursiainen K
    Oncology; 2008; 75(3-4):145-51. PubMed ID: 18824877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular alterations in bladder cancer.
    Cordon-Cardo C
    Cancer Surv; 1998; 32():115-31. PubMed ID: 10489625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer.
    Simon R; Bürger H; Brinkschmidt C; Böcker W; Hertle L; Terpe HJ
    J Pathol; 1998 Aug; 185(4):345-51. PubMed ID: 9828832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.
    Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B
    Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
    Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor gene alterations in bladder carcinoma. Translational correlates to clinical practice.
    Dalbagni G; Cordon-Cardo C; Reuter V; Fair WR
    Surg Oncol Clin N Am; 1995 Apr; 4(2):231-40. PubMed ID: 7796283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutation.
    Ecke TH; Schlechte HH; Schulze G; Lenk SV; Loening SA
    Anticancer Res; 2005; 25(1B):635-41. PubMed ID: 15816639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
    Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
    Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
    van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC
    Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of the 9q34 gene TSC1 in sporadic bladder cancer.
    Hornigold N; Devlin J; Davies AM; Aveyard JS; Habuchi T; Knowles MA
    Oncogene; 1999 Apr; 18(16):2657-61. PubMed ID: 10353610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.